Please provide your email address to receive an email when new articles are posted on . Semaglutide and tirzepatide not only reduce body weight in obesity but are also approved to treat other ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Incretin hormones, such as glucagon-like peptide-1 (GLP-1), play a crucial role in modulating insulin and glucagon secretion, as well as regulating appetite, gastric emptying, and pancreatic beta cell ...

Please provide your email address to receive an email when new articles are posted on . NEW ORLEANS — In this video, Clyde W. Yancy, MD, MSc, MACP, MACC, FAHA, FHFSA, discusses notable updates across ...

We aimed to investigate whether the reduced incretin effect observed in patients with type 2 diabetes is a primary event in the pathogenesis of type 2 diabetes or a consequence of the diabetic state.

The 2026 ADA Standards of Care really further elaborate on the benefits of incretin-based therapies. I can't go through in great detail all of the different roles that incretin-based therapies now ...

Bristol Gate Capital Partners, an investment management company, published its Q4 2025 investor letter for the “US Equity Strategy”. A copy of the letter can be downloaded here. Bristol Gate ...

Viking Therapeutics is a frontrunner in the race to secure approval for a drug to treat NASH, with its lead candidate VK2809 showing positive results in a Phase 2b study. The company also is ...

An international research group has clarified the action mechanism of incretin-based drugs in the treatment of diabetes. The research group headed by Professor SEINO Susumu included Researcher Okechi ...

The idea that the intestine produces factors following nutrient ingestion that stimulate the release of substances from the pancreas to modulate blood glucose levels first emerged in the early 1900s, ...